Bearing nsPVA for uterine fibroid embolization (UAE)
Part of Cancer clinical trials.
This trial tests a new particle material, Bearing nsPVA, for uterine artery embolization (UAE), a procedure that blocks blood flow to fibroids to shrink them and reduce symptoms like heavy bleeding or pain. It aims to see if this material is safe and effective for women with symptomatic fibroids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You have at least one uterine fibroid that is causing symptoms (like heavy periods, pain, or pressure)
- You are willing to give written permission to join the study
- You are not pregnant
- You do not have an active pelvic infection
- You have no cancer in the pelvic area (like endometrial cancer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special contrast-enhanced ultrasound (CEUS and SHAPE) to take detailed images of uterine fibroids before and after a procedure called uterine artery embolization (UAE). It aims to help doctors better understand how fibroids respond to treatment.
This trial tests a gentle electrical stimulation treatment placed near the cervix to see if it can reduce pelvic pain after a procedure called uterine fibroid embolization, which is used to shrink fibroids. It aims to give better pain relief during recovery.
This trial tests if blocking enlarged veins in the pelvis (called embolization) can reduce long-term pelvic pain that hasn't improved with other treatments. It may help women whose pain is worse when standing or walking and better when lying down.
This study is looking at whether a computer program (artificial intelligence) can help doctors better evaluate how well uterine artery embolization (UAE) worked for treating fibroids. The program analyzes the X-ray images taken during the procedure to see if it might improve outcomes for women with fibroids.
This trial tests a non-surgical procedure called uterine artery embolization to treat adenomyosis symptoms like heavy bleeding and pelvic pain. If it works, it could be an alternative to removing the uterus.
This trial tests a new way to block blood flow to the prostate to shrink it and improve urinary symptoms. It uses a special gel called SquidPERI during a standard procedure called prostate artery embolization (PAE).
Hear when a new Uterine Fibroid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.